| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.23 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |